• Globe Newswire

Persephoni Backs SelSym Biotech to Bring Blood-Type-Agnostic Bleeding Control to the Point of Injury

Globenewswire -

• Globe Newswire

Quoin Pharmaceuticals Files Breakthrough Medicine Designation Application in Saudi Arabia for QRX003 in Netherton Syndrome

Globenewswire -

• Globe Newswire

Azurity Pharmaceuticals Names Ogilvy Health as PR and Marketing Agency of Record to Drive Strategic Brand Repositioning and Enhance Market Visibility

Globenewswire -

• Globe Newswire

Persephoni Launches Strategic Sponsorship with American Cancer Society’s BrightEdge to Accelerate Oncology Innovation

Globenewswire -

• Globe Newswire

London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami